As leader is freed from prison, Sam­sung Bi­o­log­ics nabs mas­sive in­vest­ment from par­ent com­pa­ny's $205B spend­ing spree

One of biotech man­u­fac­tur­ing’s gi­ants has an­nounced a mas­sive in­vest­ment in its op­er­a­tions over the next three years.

Sam­sung Bi­o­log­ics will re­ceive a share of a $205 bil­lion in­vest­ment from its par­ent com­pa­ny, along with Sam­sung Elec­tron­ics, as the Ko­re­an com­pa­ny ramps up its semi­con­duc­tor, bio­phar­ma­ceu­ti­cals and telecom­mu­ni­ca­tions units. More than $154 bil­lion of that mon­ey will be spent right in South Ko­rea, as the com­pa­ny plans to cre­ate 40,000 new jobs by 2023. And M&A is very much on the ta­ble.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER